A<sub>2A</sub> Adenosine Receptor Antagonists and Their Efficacy in Rat Models of Parkinson’s Disease
Parkinson’s disease (PD) represents a growing challenge to global health, as it involves millions of people. The high grade of disability is due to the loss of dopaminergic neuron activity, and levodopa is the gold-standard therapy used to restore dopamine in the dopamine-denervated regions. Another...
Saved in:
| Main Authors: | Andrea Spinaci, Michela Buccioni, Diego Dal Ben, Beatrice Francucci, Karl-Norbert Klotz, Gabriella Marucci, Nicola Simola, Micaela Morelli, Annalisa Pinna, Rosaria Volpini, Catia Lambertucci |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/5/338 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adenosine A3 receptor antagonists as anti‐tumor treatment in human prostate cancer: an in vitro study
by: Maria Beatrice Morelli, et al.
Published: (2025-07-01) -
Adenosine and adenosine receptors: a “double-edged sword” in cardiovascular system
by: Yongqi Qian, et al.
Published: (2025-07-01) -
Research progress of CD73-adenosine signaling regulating hepatocellular carcinoma through tumor microenvironment
by: Liang Shan, et al.
Published: (2025-05-01) -
Synthetic Small-Molecule Ligands Targeted to Adenosine Receptors: Is There Potential Towards Ischemic Heart Disease?
by: Qi Xu, et al.
Published: (2025-08-01) -
The progress and prospects of targeting the adenosine pathway in cancer immunotherapy
by: Yuying Yang, et al.
Published: (2025-05-01)